Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Park Dental Partners, Inc. Common Stock (PARK)
USD20.65
+0.61 (+3.04%)
US NASDAQ Healthcare Medical - Equipment & Services
Address
2200 County Road C West 55113
Roseville, MN, US
Roseville, MN, US
CEO
Peter G. Swenson
Website
parkdentalpartners.com
IPO
2018-11-13
CIK 2069604 ISIN US7004021009
Description
Park Dental Partners, Inc. operates as a dental support organization, providing a wide array of non-clinical and operational assistance to dental professionals throughout Minnesota and Wisconsin. The company furnishes its network of affiliated general and multi-specialty dental practices with vital resources, including clinical and administrative staff, physical facilities, and essential equipment. Through these partnered clinics, patients can access a full spectrum of oral healthcare services, from general dentistry to specialized procedures such as oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Founded in 1972, Park Dental Partners, Inc. is headquartered in Roseville, Minnesota.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD20.65
+0.61 (+3.04%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
26.8K
Beta
0.53
Float Shares
1.12M
Free Float %
57.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.16% | +10.49% | +6.82% | +3.16% | +84.98% | +28.46% | +84.98% | +84.98% | +84.98% | +84.98% | +84.98% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
20.65
Low
21.50
+4.1%
Consensus
21.75
+5.3%
Median
21.75
+5.3%
High
22.00
+6.5%
DCF (Levered)
549.31
+2,560.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
21.75
+5.3%
|
| All Time | 2 |
21.75
+5.3%
|
Quality scores
Altman Z-Score
1,240.97
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Equipment & Services: +14.1%+106,297.0% ★ Q1'26: +102,649.2% (vs Q1'25)
-
EPS growth Medical - Equipment & Services: +15.4%-116.8% Q1'26: -107.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Equipment & Services: -3.5%-0.2% Q1'26: +4.3% (vs Q1'25)
-
EBIT margin Medical - Equipment & Services: +1.1%+0.1% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Equipment & Services: +2.4%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Equipment & Services: -2.1%+47,423.0% Q1'26: +146.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Equipment & Services: 0.31×0.03× ★ Q1'26: -7.49× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. |
|---|---|---|---|---|
| Revenue |
244.49B
est: 242.46M (+100,739.5%)
|
256.60M
254.60M – 258.60M
+5.8% YoY
|
272.43M
270.31M – 274.56M
+6.2% YoY
|
284.72M
282.50M – 286.94M
+4.5% YoY
|
| EBITDA |
1.77B
est: 10.56M (+16,621.3%)
|
11.18M
11.09M – 11.26M
+5.8% YoY
|
11.87M
11.77M – 11.96M
+6.2% YoY
|
12.40M
12.31M – 12.50M
+4.5% YoY
|
| EBIT |
250.00M
est: 3.95M (+6,223.5%)
|
4.18M
4.15M – 4.22M
+5.8% YoY
|
4.44M
4.41M – 4.48M
+6.2% YoY
|
4.64M
4.61M – 4.68M
+4.5% YoY
|
| Net Income |
-358.00M
est: 1.85B (-119.4%)
|
2.12B
2.10B – 2.14B
+14.7% YoY
|
2.57B
2.54B – 2.59B
+21.1% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
31.91B
est: 28.57M (+111,587.6%)
|
30.23M
30.00M – 30.47M
+5.8% YoY
|
32.10M
31.85M – 32.35M
+6.2% YoY
|
33.55M
33.28M – 33.81M
+4.5% YoY
|
| EPS |
-0.18
est: 0.95 (-118.9%)
|
1.09
1.08 – 1.10
+14.7% YoY
|
1.32
1.31 – 1.33
+21.1% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
73.78B
OE per share TTM
35.16
Owner's Yield
156.45%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
30.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.01% | 109.3K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 364.6K | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 229.89 | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 631.21 | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 46.62 | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 107.9K | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 236.72 | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 129.11 | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 51.99 | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 5.72 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
207.0K
Shares Outstanding
1.94M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Peter G. Swenson Chairman of the Board, President and Chief Executive Officer | 602.6K | 584.2K | — | — | — | 19.4K | 1.21M | 0.00% | ↗ |
| 2 | 2025 | Dr. Alan Law , Chief Clinical Officer, Specialty Practices | 675.3K | 97.0K | — | — | — | 106.3K | 878.5K | 0.00% | ↗ |
| 3 | 2025 | Dr. Christopher Steele , Chief Clinical Officer, General Practices | 529.3K | 193.9K | — | — | — | 18.6K | 741.9K | 0.00% | ↗ |
| 4 | 2025 | Christopher J. Bernander, Chief Financial Officer, Treasurer | 425.0K | 274.7K | — | — | — | 16.1K | 715.8K | 0.00% | ↗ |
| 5 | 2024 | Peter G. Swenson Chairman of the Board, President and Chief Executive Officer | 602.5K | 377.0K | — | — | — | 47.6K | 2.63M | 0.00% | ↗ |
| 6 | 2024 | Dr. Alan Law , Chief Clinical Officer, Specialty Practices | 777.4K | 62.6K | — | — | — | 50.1K | 999.4K | 0.00% | ↗ |
| 7 | 2024 | Christopher J. Bernander, Chief Financial Officer, Treasurer | 425.0K | 177.3K | — | — | — | 11.0K | 979.9K | 0.00% | ↗ |
| 8 | 2024 | Dr. Christopher Steele , Chief Clinical Officer, General Practices | 524.5K | 125.1K | — | — | — | 16.3K | 777.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter G. Swenson | President, CEO & Chairman of the Board | 1M | male |
| Alan Siems | Chief Clinical Officer of Specialty Practices & Director | 796.2K | — |
| Christopher E. Steele | Chief Clinical Officer of General Practices & Director | 736.0K | — |
| Christopher James Bernander | CFO & Treasurer | 715.8K | male |
| Brian Zard | Vice President of Operations | — | male |
| David Johnson | Controller | — | male |
| Jean Lind | Chief Administrative Officer & Secretary | — | female |
| Brian Delgado | Senior Director of Marketing | — | male |
ESG Rating
ESG Score History MEDICAL - EQUIPMENT & SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PARK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
